GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $313,000 | -94.6% | 7,188 | -94.6% | 0.00% | -93.0% |
| Q1 2022 | $5,815,000 | +906.1% | 133,498 | +918.7% | 0.04% | +1333.3% |
| Q4 2021 | $578,000 | +16.8% | 13,105 | +1.2% | 0.00% | +50.0% |
| Q3 2021 | $495,000 | -97.5% | 12,947 | -97.4% | 0.00% | -97.8% |
| Q2 2021 | $19,695,000 | +2737.9% | 494,605 | +2441.9% | 0.09% | +2200.0% |
| Q1 2021 | $694,000 | -42.7% | 19,458 | -40.9% | 0.00% | -33.3% |
| Q4 2020 | $1,211,000 | -30.2% | 32,905 | -28.7% | 0.01% | -45.5% |
| Q3 2020 | $1,736,000 | -55.3% | 46,126 | -51.5% | 0.01% | -65.6% |
| Q2 2020 | $3,880,000 | +13.0% | 95,114 | +4.9% | 0.03% | 0.0% |
| Q1 2020 | $3,435,000 | -59.6% | 90,659 | -49.9% | 0.03% | -59.0% |
| Q4 2019 | $8,501,000 | -24.3% | 180,921 | -31.2% | 0.08% | -15.2% |
| Q3 2019 | $11,226,000 | -16.3% | 263,022 | -21.5% | 0.09% | 0.0% |
| Q2 2019 | $13,417,000 | +384.4% | 335,267 | +405.9% | 0.09% | +268.0% |
| Q1 2019 | $2,770,000 | -53.9% | 66,273 | -57.9% | 0.02% | -52.8% |
| Q4 2018 | $6,014,000 | +8.8% | 157,383 | +14.4% | 0.05% | +29.3% |
| Q3 2018 | $5,528,000 | -17.7% | 137,607 | -17.5% | 0.04% | -32.8% |
| Q2 2018 | $6,720,000 | +31.1% | 166,706 | +27.1% | 0.06% | +48.8% |
| Q1 2018 | $5,125,000 | -40.3% | 131,187 | -45.8% | 0.04% | -48.8% |
| Q4 2017 | $8,580,000 | +609.7% | 241,894 | +712.2% | 0.08% | +627.3% |
| Q3 2017 | $1,209,000 | +203.0% | 29,781 | +214.5% | 0.01% | +175.0% |
| Q1 2017 | $399,000 | +37.1% | 9,470 | +40.8% | 0.00% | +100.0% |
| Q2 2016 | $291,000 | -77.8% | 6,725 | -80.3% | 0.00% | -75.0% |
| Q3 2015 | $1,310,000 | -88.8% | 34,072 | -87.8% | 0.01% | -89.6% |
| Q2 2015 | $11,664,000 | +830.1% | 280,046 | +930.3% | 0.08% | +1000.0% |
| Q1 2015 | $1,254,000 | -20.6% | 27,180 | -26.5% | 0.01% | -12.5% |
| Q4 2014 | $1,580,000 | +154.4% | 36,960 | +173.5% | 0.01% | +100.0% |
| Q3 2014 | $621,000 | +404.9% | 13,516 | +489.2% | 0.00% | +300.0% |
| Q2 2014 | $123,000 | -95.1% | 2,294 | -95.1% | 0.00% | -90.9% |
| Q1 2014 | $2,486,000 | – | 46,524 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |